Literature DB >> 24500589

Thirty and ninety-day reoperation rates after shoulder arthroplasty.

Philipp N Streubel1, Juan P Simone1, John W Sperling1, Robert Cofield1.   

Abstract

BACKGROUND: The purpose of the present study was to assess thirty and ninety-day reoperation rates after shoulder arthroplasty from 2000 to 2010.
METHODS: Our institution's joint registry was queried to identify shoulder arthroplasties performed from January 2000 to December 2010. Data regarding patient demographics and the type of procedure were reviewed. Reoperations within thirty and ninety days after the index procedure were analyzed. During the eleven-year study period, 2305 primary arthroplasties (502 hemiarthroplasties, 1440 anatomic total shoulder arthroplasties, and 363 reverse total shoulder arthroplasties) and 518 revision arthroplasties (twenty-one hemiarthroplasties, 356 anatomic total arthroplasties, and 141 reverse arthroplasties) were performed. Fifty-four percent of patients were female; mean age was sixty-eight years (range, eighteen to ninety-seven years) and body mass index was 30.3 kg/m2 (range, 14.7 to 65.9 kg/m2).
RESULTS: Reoperation was required within thirty days after fourteen primary arthroplasties (0.6%) and eight revision arthroplasties (1.5%); it was required within ninety days after thirty-two primary arthroplasties (1.4%) and thirteen revision arthroplasties (2.5%). The most frequent causes for reoperation after primary and revision arthroplasty were instability (n = 14 and 6) and infection (n = 13 and 3). The mean number of additional procedures required was 1.3 (range, one to four) for primary arthroplasties and 1.8 (range, one to three) for revision arthroplasties; 20% of patients undergoing reoperation required two or more additional procedures. Reoperations led to readmission in 82% of cases.
CONCLUSIONS: Short-term reoperation after shoulder arthroplasty was infrequent. Wound complications and shoulder instability were the most frequent causes for reoperation. Reoperation was twice as frequent after revision surgery as after primary shoulder arthroplasty.

Entities:  

Mesh:

Year:  2014        PMID: 24500589     DOI: 10.2106/JBJS.M.00127

Source DB:  PubMed          Journal:  J Bone Joint Surg Am        ISSN: 0021-9355            Impact factor:   5.284


  7 in total

1.  What Are Risk Factors for 30-day Morbidity and Transfusion in Total Shoulder Arthroplasty? A Review of 1922 Cases.

Authors:  Chris A Anthony; Robert W Westermann; Yubo Gao; Andrew J Pugely; Brian R Wolf; Carolyn M Hettrich
Journal:  Clin Orthop Relat Res       Date:  2014-12-19       Impact factor: 4.176

2.  Is Hepatitis C Infection Associated With a Higher Risk of Complications After Total Shoulder Arthroplasty?

Authors:  Jourdan M Cancienne; Ian J Dempsey; Russell E Holzgrefe; Stephen F Brockmeier; Brian C Werner
Journal:  Clin Orthop Relat Res       Date:  2016-07-22       Impact factor: 4.176

3.  Analysis of 90-Day Readmissions After Total Shoulder Arthroplasty.

Authors:  Andrew S Chung; Justin L Makovicka; Thomas Hydrick; Kelly L Scott; Varun Arvind; Steven J Hattrup
Journal:  Orthop J Sports Med       Date:  2019-09-24

4.  Early aseptic reoperation after shoulder arthroplasty increases risk of subsequent prosthetic joint infection.

Authors:  John R Wickman; Daniel E Goltz; Jay M Levin; Tally Lassiter; Oke A Anakwenze; Christopher S Klifto
Journal:  JSES Int       Date:  2021-08-05

5.  Is it worth the risk? Clinical and radiographic outcomes 24 months after reverse shoulder arthroplasty in an advanced geriatric population.

Authors:  David Endell; Laurent Audigé; Jan-Philipp Imiolczyk; Markus Scheibel; Florian Freislederer
Journal:  JSES Int       Date:  2022-06-09

6.  Ambulatory versus inpatient shoulder arthroplasty: a population-based analysis of trends, outcomes, and charges.

Authors:  Gabriella E Ode; Susan Odum; Patrick M Connor; Nady Hamid
Journal:  JSES Int       Date:  2020-01-03

7.  Complication rates and outcomes after outpatient shoulder arthroplasty: a systematic review.

Authors:  Hailey P Huddleston; Nabil Mehta; Evan M Polce; Brady T Williams; Michael C Fu; Adam B Yanke; Nikhil N Verma
Journal:  JSES Int       Date:  2021-01-16
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.